BCAX Competitors & Alternatives
Compare Bicara Therapeutics Inc. Common Stock with similar stocks in the same industry
Biotechnology
BCAX
Main Stock$23.90
Tradestie Score
52
Market Cap
$906.29M
Analyst Upside
+40.2%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLDX
Celldex Therapeutics, Inc
|
$40.38
|
$1.68B | - | 50 | Compare |
|
MNKD
Mannkind Corporation
|
$4.15
|
$1.65B | - | 52 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$44.18
|
$1.63B | - | 50 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.85
|
$1.57B | - | 49 | Compare |
|
VCEL
Vericel Corporation
|
$42.68
|
$1.56B | 87.7 | 53 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$111.10
|
$1.55B | - | 42 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$38.15
|
$1.55B | 12.9 | 49 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$36.27
|
$1.55B | - | 44 | Compare |
|
NVAX
Novavax Inc
|
$8.94
|
$1.54B | - | 38 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.65
|
$1.50B | 7.6 | 40 | Compare |
More BCAX Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry